News|Slideshows|November 10, 2022

Obesity Research Roundup for Primary Care: 5 Studies At-a-Glance from ObesityWeek® 2022

Semaglutide yields "amazing" weight loss in adolescents, phenotype-tailored lifestyle approach leads to greater weight loss vs standard methods, and more.

Treatment options for patients with obesity have come a long way in recent years and more therapies are in development across the pharmaceutical industry. The vast majority of obesity, however, goes untreated. The Obesity Society's annual meeting, ObesityWeek® 2022, focused on ways to bridge the gap and scale up obesity treatment. Below, find briefs on 5 clinical trials presented at the meeting that may impact your clinical practice.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.


Latest CME